Clinical Trials Browser

Prostatic Neoplasms × Saline Solution × Clear all

Erectile Dysfunction, Prostatic Neoplasms

NCT03834493 2025-07-18

KEYNOTE-641

Phase 3 Active not recruiting

1,244 enrolled 21 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03824808 2023-10-25

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Phase 4 Terminated

21 enrolled 12 charts

Genitourinary

Kidney Neoplasms, Prostatic Neoplasms

NCT03232125 2020-08-25

Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

Phase NA Completed

54 enrolled

Genitourinary

Prostatic Neoplasms

NCT02833038 2019-04-05

Effect of Intravenous Magnesium During Robot Assisted Prostatectomy

Phase NA Completed

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT03529643 2018-09-13

Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALP

Phase NA Completed

128 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Stem Cells for Erectile Dysfunction Post RALP

KEYNOTE-641

KEYNOTE-921

ERA 223

KEYNOTE-921

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

Effect of Intravenous Magnesium During Robot Assisted Prostatectomy

Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALP